Ask Warren

NGeneBio

354200 · KOSDAQ · ₩354200 · 엔젠바이오

₩681▼ ₩31 (4.35%)End-of-day · Oct 27, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

20252024202320222021
Revenue₩21B₩5.7B₩4.4B₩11B₩7.2B
Cost of sales₩17B₩3.5B₩4.5B₩6.9B₩4.8B
Gross profit₩3.8B₩2.1B−₩139M₩4.1B₩2.4B
Operating income−₩8.3B−₩16B−₩13B−₩8.6B−₩8.7B
Net income−₩6.8B−₩14B−₩13B−₩9.8B−₩8.4B
Net income to shareholders−₩5.5B−₩13B−₩13B−₩9.8B−₩8.4B

Balance sheet

20252024202320222021
Total assets₩72B₩33B₩42B₩56B₩44B
Current assets₩24B₩12B₩27B₩43B₩27B
Cash and equivalents₩1.9B₩4.4B₩19B₩25B₩16B
Total liabilities₩50B₩15B₩26B₩31B₩9.9B
Current liabilities₩48B₩13B₩24B₩29B₩8.1B
Borrowings₩33B₩6.7B₩11B₩11B₩7B
Total equity₩23B₩18B₩16B₩25B₩34B
Shareholders' equity₩23B₩17B₩16B₩25B₩34B

Cash flow

20252024202320222021
Cash from operations−₩8.5B−₩12B−₩9.2B−₩7.8B−₩7.5B
Capital spending₩57M₩135M₩386M₩1B₩3B
Free cash flow−₩8.5B−₩13B−₩9.6B−₩8.8B−₩11B

Consolidated where available. Amounts in won.

Also known as: NGeneBio / 엔젠바이오 / 354200 / KRX:354200

Source: KRX statistical information